what is a glp-1 receptor agonist PDB-101: Molecule of the Month: Agonists What is GLP-1 and Its
Description
Shima Hadidchi, MD , takes a personalized approach to monitoring her patients progress on semaglutide GLP-1 or Zepbound for weight loss
They need affordable access and sustained access, she says
Losing insurance coverage and stopping overnight
doi: 10.1007/s40257-024-00911-x
Wong HJ, Sim B, Teo YH, Teo YN, Chan MY, Yeo LLL, et al
In the interim analysis of a phase III study (REGENERATE trial) at 18 months, 931 NASH patients with stage 23 fibrosis were randomly assigned to placebo and showed significant fibrosis improvement without NASH deterioration
